Diagnosing Healthcare-Associated Infections (HAIs)

Temporal Diagnostic Criteria

• Healthcare-associated infections are diagnosed based on temporal criteria (>48 hours after hospital admission or within 7 days post-discharge) combined with clinical evidence of infection and positive microbiological testing, with the specific diagnostic approach varying by infection type 1
• The fundamental diagnostic requirement is timing: infections must develop more than 48 hours after hospital admission OR within 7 days after hospital discharge to be classified as healthcare-associated 1

Expanded Healthcare-Associated Risk Factors

• Consider HAI diagnosis in patients with recent hospitalization within 90 days 1
• Consider HAI diagnosis in patients with nursing facility residence 1
• Consider HAI diagnosis in patients with aggressive medical therapies at home within 30 days (e.g., IV antibiotics, wound care, chemotherapy) 1
• Consider HAI diagnosis in patients with invasive outpatient procedures within 30 days (e.g., hemodialysis, endoscopy) 1
• Consider HAI diagnosis in patients with presence of invasive devices at admission (central lines, urinary catheters, ventilators) 1, 2
• Consider HAI diagnosis in patients with history of MRSA colonization or infection 1, 2
• Consider HAI diagnosis in patients with prior surgery or hospitalization 1, 2

Site-Specific Diagnostic Approaches

Intra-Abdominal HAIs

• Diagnosis requires both clinical evidence AND microbiological confirmation: clinical criteria include fever, abdominal pain, peritoneal signs, or evidence of organ dysfunction 3
• Imaging includes ultrasonography as first-line for suspected acute cholecystitis; CT for complex infections 3
• Microbiological work-up includes culture infected fluid to identify pathogens and guide antimicrobial therapy 3, 2
• Expected pathogens include multidrug-resistant organisms including P. aeruginosa, Acinetobacter, ESBL-producing Enterobacteriaceae, MRSA, enterococci, and Candida species 3, 2, 4

Clostridioides difficile Infection (CDI)

• CDI diagnosis requires BOTH presence of diarrhea OR evidence of megacolon/severe ileus AND positive laboratory test (toxin EIA or NAAT) OR pseudomembranes on endoscopy/histopathology 5
• Classification by timing includes healthcare facility-onset (HO-CDI): positive test >3 days after admission (day 4 or later) 5
• Classification by timing includes community-onset, healthcare facility-associated (CO-HCFA): positive test within 28 days after discharge 5

Device-Associated HAIs

• Surgical site infections (SSI) are diagnosed as infection at surgical site within 30 days of procedure (or 90 days if implant placed) 6

Microbiological Diagnosis

Culture Requirements

• Obtain cultures BEFORE initiating empiric antibiotics whenever possible 3, 2
• Blood cultures include minimum 2 sets from separate sites for suspected bacteremia 3
• Site-specific cultures include infected fluid, tissue, or device tips as appropriate 3, 2
• Repeat cultures are done after 48-72 hours of therapy to document clearance in serious infections 7

Antimicrobial Susceptibility Testing

• Perform susceptibility testing on all significant isolates to guide therapy 3, 2
• Local antibiogram review is done to understand institutional resistance patterns 3, 2
• Test for specific resistance mechanisms: MRSA, ESBL, carbapenemase production 3, 2, 4

Surveillance and Monitoring

Institutional Surveillance

• All healthcare facilities should track healthcare facility-onset (HO) cases using standardized definitions 5
• Minimum surveillance includes HO-CDI cases (>3 days after admission) 5
• Denominator includes patient-days (not admissions) for accurate rate calculation 5
• Risk adjustment includes accounting for test type sensitivity (NAAT vs. toxin EIA) and community-onset prevalence 5
• Stratification includes by hospital location or clinical service when rates exceed baseline 5

Outcome Monitoring

• Track severe outcomes attributable to HAIs, including colectomy, ICU admission, and death 5

Critical Diagnostic Pitfalls

False-Positive Considerations

• Distinguish true infection from colonization or contamination 8
• Mycobacterial pseudo-outbreaks are often due to contaminated water systems, bronchoscopes, or terminal rinse water rather than true infection 8
• Single positive blood culture may represent contamination; clinical correlation essential 3

Test Sensitivity Issues

• NAAT testing for C. difficile is more sensitive than toxin EIA, leading to higher reported rates 5
• NAAT detects toxin genes (higher sensitivity) 5
• Toxin EIA detects actual toxin (higher specificity) 5
• Clinical correlation required to distinguish colonization from disease 5

Timing Exceptions

• Infections beyond 7 days post-discharge are generally community-acquired UNLESS ongoing home healthcare interventions are present, recent outpatient invasive procedures were performed, or surgical site infection is related to prior hospitalization 1

Prevention as Diagnostic Context

• Multifaceted interventions can reduce HAI rates by 35-55% 6